$800,000 MaRS Innovation–Pfizer Translational Research Fund
KIRKLAND, Quebec and TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- Pfizer Canada is proud to announce an $800,000 contribution to MaRS Innovation to support the vision and mission of MaRS…
Encycle Therapeutics announces discovery collaboration with Pfizer Inc.
TORONTO, November 1, 2017 – Encycle Therapeutics (“Encycle”), a Toronto-based drug discovery company built on a unique chemistry that enables the synthesis of a new type of constrained peptide called…
MaRS Innovation and Pfizer fund Bio-Manufacturing Technology
Technology developed by Dr. Stuart Berger at UHN is first project funded through partnership TORONTO, Dec. 11, 2013 - MaRS Innovation, a Centre of Excellence for Commercialization and Research, has announced…
MaRS Innovation announces new strategic partnership with Pfizer
TORONTO, April 22, 2013 — MaRS Innovation, a Centre of Excellence for Commercialization and Research, today announced the formation of a strategic partnership with Pfizer Inc. to advance early-stage technologies…
Dr. Laszlo Radvanyi
Dr. Laszlo Radvanyi brings a strong oncology research background in academia as well as leadership experience in international pharma and biotech, making him an ideal leader for OICR. Laszlo was…
Joyce Lin
Joyce Lin, CPA, CA was Associate Director, Finance at Trillium Therapeutics, a clinical stage immuno-oncology company acquired by Pfizer in 2021. At Trillium Therapeutics, Joyce led end-to-end finance functions, including…
LAB150 adds project with focus on mental health
Toronto, ON, June 11, 2019 (GLOBE NEWSWIRE) -- It is estimated that 5% of the global population is affected by Major Depressive Disorder (MDD) at any given time. While there…
FIRST FUNDED PROJECT UNDER LAB150 BRIDGE ANNOUNCED!
Hamburg, Germany, and Toronto, Canada, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation announced today that they have identified the…
LAB150 – Strategic Partnership with Evotec AG
Toronto, Sept. 14, 2017 (GLOBE NEWSWIRE) -- MaRS Innovation (“MI”) and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the launch of “LAB150”. This transformational Toronto-based partnership…
Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics
Toronto, Canada and Hamburg, Germany, 17 January 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP (“Fibrocor”), a…